Skip to Content
Upcoming Webinar

Advancing Operational Excellence: Optimizing ESR1 Testing in Oncology Care

Date: April 16, 2025 | 2:00 PM

 

 

Join us for an in-depth exploration of endocrine therapy resistance in HR+, HER2- advanced breast cancer, with a focus on ESR1 mutations and their impact on treatment decisions.

This session will cover essential insights to guide clinical practice:

  • Types of endocrine therapy resistance and the role of ESR1 mutations

  • Testing guidelines and clinical implementation of ESR1 mutation testing

  • Available therapies targeting ESR1 mutations and best practices for patient care

 

Speakers:
Julia Lea Ziegengeist, PharmD, BCOP | Atrium Health
Heather N. Moore, PharmD, BCOP, CPP | Duke University Hospital

 

If you have any questions or would like to request the meeting invite, contact Jonathan Rivera.

Login